These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 19238634)

  • 1. Reduced expression of a gene proliferation signature is associated with enhanced malignancy in colon cancer.
    Anjomshoaa A; Lin YH; Black MA; McCall JL; Humar B; Song S; Fukuzawa R; Yoon HS; Holzmann B; Friederichs J; van Rij A; Thompson-Fawcett M; Reeve AE
    Br J Cancer; 2008 Sep; 99(6):966-73. PubMed ID: 19238634
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Stromal responses among common carcinomas correlated with clinicopathologic features.
    Chen JL; Espinosa I; Lin AY; Liao OY; van de Rijn M; West RB
    Clin Cancer Res; 2013 Sep; 19(18):5127-35. PubMed ID: 23804424
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Isolation and characterization of calcium sensing receptor null cells: a highly malignant and drug resistant phenotype of colon cancer.
    Singh N; Liu G; Chakrabarty S
    Int J Cancer; 2013 May; 132(9):1996-2005. PubMed ID: 23055106
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Functional analysis of B7-H3 in colonic carcinoma cells.
    Lu P; Liu R; Ma EM; Yang TJ; Liu JL
    Asian Pac J Cancer Prev; 2012; 13(8):3899-903. PubMed ID: 23098490
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of an aldo-keto reductase gene signature with prognostic significance in colon cancer via activation of epithelial to mesenchymal transition and the p70S6K pathway.
    Demirkol Canlı S; Seza EG; Sheraj I; Gömçeli I; Turhan N; Carberry S; Prehn JHM; Güre AO; Banerjee S
    Carcinogenesis; 2020 Sep; 41(9):1219-1228. PubMed ID: 32628753
    [TBL] [Abstract][Full Text] [Related]  

  • 6. IMP3 is a novel prognostic marker that correlates with colon cancer progression and pathogenesis.
    Li D; Yan D; Tang H; Zhou C; Fan J; Li S; Wang X; Xia J; Huang F; Qiu G; Peng Z
    Ann Surg Oncol; 2009 Dec; 16(12):3499-506. PubMed ID: 19672661
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Novel effect of antihelminthic Niclosamide on S100A4-mediated metastatic progression in colon cancer.
    Sack U; Walther W; Scudiero D; Selby M; Kobelt D; Lemm M; Fichtner I; Schlag PM; Shoemaker RH; Stein U
    J Natl Cancer Inst; 2011 Jul; 103(13):1018-36. PubMed ID: 21685359
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Wnt5a promotes human colon cancer cell migration and invasion but does not augment intestinal tumorigenesis in Apc1638N mice.
    Bakker ER; Das AM; Helvensteijn W; Franken PF; Swagemakers S; van der Valk MA; ten Hagen TL; Kuipers EJ; van Veelen W; Smits R
    Carcinogenesis; 2013 Nov; 34(11):2629-38. PubMed ID: 23764752
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognostic significance of downregulated expression of the candidate tumour suppressor gene SASH1 in colon cancer.
    Rimkus C; Martini M; Friederichs J; Rosenberg R; Doll D; Siewert JR; Holzmann B; Janssen KP
    Br J Cancer; 2006 Nov; 95(10):1419-23. PubMed ID: 17088907
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Msi-1 is a predictor of survival and a novel therapeutic target in colon cancer.
    Li D; Peng X; Yan D; Tang H; Huang F; Yang Y; Peng Z
    Ann Surg Oncol; 2011 Jul; 18(7):2074-83. PubMed ID: 21442350
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CDX2 as a Prognostic Biomarker in Stage II and Stage III Colon Cancer.
    Dalerba P; Sahoo D; Paik S; Guo X; Yothers G; Song N; Wilcox-Fogel N; Forgó E; Rajendran PS; Miranda SP; Hisamori S; Hutchison J; Kalisky T; Qian D; Wolmark N; Fisher GA; van de Rijn M; Clarke MF
    N Engl J Med; 2016 Jan; 374(3):211-22. PubMed ID: 26789870
    [TBL] [Abstract][Full Text] [Related]  

  • 12. WiNTRLINC1/ASCL2/c-Myc Axis Characteristics of Colon Cancer with Differentiated Histology at Young Onset and Essential for Cell Viability.
    Yokota K; Tanaka Y; Harada H; Kaida T; Nakamoto S; Soeno T; Fujiyama Y; Yokota M; Kojo K; Miura H; Yamanashi T; Sato T; Nakamura T; Watanabe M; Yamashita K
    Ann Surg Oncol; 2019 Dec; 26(13):4826-4834. PubMed ID: 31549316
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Epigenetic silencing of the sulfate transporter gene DTDST induces sialyl Lewisx expression and accelerates proliferation of colon cancer cells.
    Yusa A; Miyazaki K; Kimura N; Izawa M; Kannagi R
    Cancer Res; 2010 May; 70(10):4064-73. PubMed ID: 20460514
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of CD44(high)/CD133(high) HCT-116 cells in the tumorigenesis of colon cancer.
    Zhou JY; Chen M; Ma L; Wang X; Chen YG; Liu SL
    Oncotarget; 2016 Feb; 7(7):7657-66. PubMed ID: 26840024
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differential regulation and predictive potential of MacroH2A1 isoforms in colon cancer.
    Sporn JC; Jung B
    Am J Pathol; 2012 Jun; 180(6):2516-26. PubMed ID: 22542848
    [TBL] [Abstract][Full Text] [Related]  

  • 16. IL-32θ inhibits stemness and epithelial-mesenchymal transition of cancer stem cells via the STAT3 pathway in colon cancer.
    Bak Y; Kwon T; Bak IS; Hong J; Yu DY; Yoon DY
    Oncotarget; 2016 Feb; 7(6):7307-17. PubMed ID: 26824417
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differentiation of high-risk stage I and II colon tumors based on evaluation of CAV1 gene expression.
    Kitowska A; Wesserling M; Seroczynska B; Szutowicz A; Ronowska A; Peksa R; Pawelczyk T
    J Surg Oncol; 2015 Sep; 112(4):408-14. PubMed ID: 26251082
    [TBL] [Abstract][Full Text] [Related]  

  • 18. JAM-A expression positively correlates with poor prognosis in breast cancer patients.
    McSherry EA; McGee SF; Jirstrom K; Doyle EM; Brennan DJ; Landberg G; Dervan PA; Hopkins AM; Gallagher WM
    Int J Cancer; 2009 Sep; 125(6):1343-51. PubMed ID: 19533747
    [TBL] [Abstract][Full Text] [Related]  

  • 19. circRNA_100859 functions as an oncogene in colon cancer by sponging the miR-217-HIF-1α pathway.
    Zhou P; Xie W; Huang HL; Huang RQ; Tian C; Zhu HB; Dai YH; Li ZY
    Aging (Albany NY); 2020 Jul; 12(13):13338-13353. PubMed ID: 32644049
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression signature defined by FOXM1-CCNB1 activation predicts disease recurrence in non-muscle-invasive bladder cancer.
    Kim SK; Roh YG; Park K; Kang TH; Kim WJ; Lee JS; Leem SH; Chu IS
    Clin Cancer Res; 2014 Jun; 20(12):3233-43. PubMed ID: 24714775
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.